甲状腺功能低下症对中风的影响仅限于特定的亚型:孟德尔的随机化研究.
Xinmin Deng1, Wen Chang1, Jingyi Zhu1
1Chengdu University of Traditional Chinese Medicine, China.
概括
甲状腺功能低下症与特定中风亚型,特别是小血管中风 (SVS) 的风险增加有关. 这种因果关系凸显了甲状腺功能低下症作为SVS潜在的独立风险因素.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 遗传学 遗传学 是一个
背景情况:
- 甲状腺功能低下症和中风风险之间的关系受到争论.
- 对甲状腺功能低下对特定中风亚型的影响的研究是有限的.
研究的目的:
- 通过使用孟德尔随机化 (MR) 调查甲状腺功能低下对中风及其亚型的因果关系.
主要方法:
- 利用来自GWAS的单核酸多态 (SNPs) 作为甲状腺功能低下症的仪器变量.
- 对中风和亚型 (AS,AIS,LAS,CES,SVS,ICH) 的分析总结GWAS数据.
- 采用单变量和多变量门德尔随机化 (UVMR,MVMR) 进行因果效应评估.
主要成果:
- 单变性MR表明甲状腺功能低下与大血管中风 (LAS) 和小血管中风 (SVS) 相关.
- 多变量MR,调整风险因素,证实甲状腺功能低下症和SVS之间存在显著的因果关系.
- 经过对共变量进行调整后,甲状腺功能低下症和LAS之间的关联并不显著.
结论:
- 甲状腺功能低下症与LAS和SVS的风险有因果关系.
- 甲状腺功能低下症可能独立地导致SVS风险.
- 血管风险因素在甲状腺功能低下症和LAS之间的关联中至关重要.
相关概念视频
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
160
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
160
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
84
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84
Hyperthyroidism II: Pathophysiology
36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36
Hypothyroidism II: Pathophysiology
35
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
35
Stroke: Introduction and Types
69
A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
69
Ischemic Stroke l: Introduction
53
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
53


